Clinical trial
A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
NCT01870401 is registered in ClinicalTrials.gov with C. R. Bard as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-Knee (BTK) Arteries(Lutonix BTK Trial)
- Lead sponsor
- C. R. Bard
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 3, 2013
- Completion date
- June 22, 2021
- Enrollment
- 442 (actual)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.
critical limb ischemia